O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.57%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.43B
AUM Growth
–
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
99.27%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
117
New
107
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$258M |
| 2 |
Gilead Sciences
GILD
|
$247M |
| 3 |
Biogen
BIIB
|
$221M |
| 4 |
Merck
MRK
|
$192M |
| 5 |
Viatris
VTRS
|
$155M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.21% |
| 2 | Financials | 2.18% |
| 3 | Technology | 0.15% |
| 4 | Utilities | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTR
76
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $7.76M | 0.16% |
+536,000
| New | +$7.76M |
|
77
InspireMD
NSPR
$101M
| $7.5M | 0.16% |
+1
| New | +$7.5M |
|
78
Stryker
SYK
$149B
| $7.43M | 0.16% |
+114,800
| New | +$7.43M |
|
|
SVA
79
DELISTED
Sinovac Biotech, Ltd
SVA
| $7.41M | 0.16% |
+1,884,200
| New | +$7.41M |
|
|
STJ
80
DELISTED
St Jude Medical
STJ
| $6.62M | 0.14% |
+145,000
| New | +$6.62M |
|
|
VCRA
81
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.58M | 0.14% |
+447,500
| New | +$6.58M |
|
|
ARQL
82
DELISTED
Arqule Inc
ARQL
| $6.51M | 0.14% |
+2,804,000
| New | +$6.51M |
|
83
Curis
CRIS
$21.5M
| $6.22M | 0.13% |
+19,501
| New | +$6.22M |
|
84
Zimmer Biomet
ZBH
$20.8B
| $6.09M | 0.13% |
+83,739
| New | +$6.09M |
|
85
Bio-Techne
TECH
$8.3B
| $5.94M | 0.13% |
+344,000
| New | +$5.94M |
|
|
CFN
86
DELISTED
CAREFUSION CORPORATION
CFN
| $5.71M | 0.12% |
+154,900
| New | +$5.71M |
|
87
Jazz Pharmaceuticals
JAZZ
$7.99B
| $4.95M | 0.1% |
+72,000
| New | +$4.95M |
|
|
FRX
88
DELISTED
FOREST LABORATORIES INC
FRX
| $4.92M | 0.1% |
+120,000
| New | +$4.92M |
|
|
ACHN
89
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $4.46M | 0.09% |
+545,000
| New | +$4.46M |
|
|
CBST
90
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $4.35M | 0.09% |
+90,000
| New | +$4.35M |
|
|
BCR
91
DELISTED
CR Bard Inc.
BCR
| $4.13M | 0.09% |
+38,000
| New | +$4.13M |
|
92
Zoetis
ZTS
$67.6B
| $4.07M | 0.09% |
+131,732
| New | +$4.07M |
|
|
CVD
93
DELISTED
COVANCE INC.
CVD
| $3.66M | 0.08% |
+48,000
| New | +$3.66M |
|
|
CELGZ
94
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $3.66M | 0.08% |
+500,000
| New | +$3.66M |
|
|
QCOR
95
DELISTED
QUESTCOR PHARMA INC
QCOR
| $3.64M | 0.08% |
+80,000
| New | +$3.64M |
|
|
AMRN
96
Amarin Corp
AMRN
$311M
| $3.48M | 0.07% |
+30,000
| New | +$3.48M |
|
|
ANTH
97
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $3.43M | 0.07% |
+116,594
| New | +$3.43M |
|
98
Edwards Lifesciences
EW
$47.7B
| $3.36M | 0.07% |
+300,000
| New | +$3.36M |
|
|
UPI
99
DELISTED
UROPLASTY INC-NEW
UPI
| $2.99M | 0.06% |
+1,443,500
| New | +$2.99M |
|
|
BLRX
100
BioLineRX
BLRX
$15.5M
| $2.58M | 0.05% |
+2,649
| New | +$2.58M |
|